Article
Telomerase immortalization of human mammary epithelial cells derived from a BRCA2 mutation carrier.
Breast cancer research and treatment - 1 Sept 2006
Lewis Cheryl M, Herbert Brittney-Shea, Bu Dawei, Halloway Shane, Beck Adam, Shadeo Ashleen, Zhang Cindy, Ashfaq Raheela, Shay Jerry W, Euhus David M
Abstract excerpt
A novel human mammary epithelial cell line, HME348, was established from benign breast tissue from a 44-year-old germ-line BRCA2 mutation carrier with a history of stage 1 breast cancer. Mutation analysis showed that the patient had a known 6872del4 BRCA2 heterozygous mutation. The human mammary epithelial cells passaged in culture exhibited cellular replicative aging as evidenced by telomere shortening, lack of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.